Related by context. All words. (Click for frequent words.) 56 PFO migraine 55 trodusquemine 54 PRECISE trial 54 RESTORE CLI 53 Levacor 53 inhaled AAT 52 HDL Selective Delipidation 52 Genomic Grade 52 prospective multicenter study 52 PACCE 52 Diastolic Heart Failure 52 BrachySil TM 52 IIa trials 52 Feasibility Trial 52 Phase Ib study 51 rotary VAD 51 Phase 2b kidney transplant 51 Peripheral Arterial 51 BrainGate TM 51 Infarct 51 Zemplar Capsules 51 MEND CABG 51 multicenter Phase II 50 ACCLAIM II 50 Phase IIB 50 prospective multicentre 50 multicenter randomized controlled 50 Cintredekin besudotox 50 StemEx R 50 cortical stimulation 50 pharmacokinetic PK study 50 Exhale Drug Eluting 50 AFRS TM 50 multicenter phase 50 Randomized Evaluation 50 BrachySil ™ 50 Pre RELAX AHF 50 gastroesophageal cancer 50 Phase Ib II 50 Prospective Randomized 50 CellSearch ™ 49 phase IIIb 49 ZYBRESTAT TM 49 eprotirome 49 Percutaneous Tibial Nerve Stimulation 49 phase IIa 49 LUMINATE 49 MIST II 49 Virtual Histology 49 immunotherapeutic vaccine 49 Zenvia Phase III 49 Radient Pharmaceutical current 49 Vernakalant 49 Phase #b/#a 49 Diamondback #deg 49 APPRAISE 49 Ablation System 49 Endovascular Graft 49 EchoCRT 49 Neo Bladder Augment 49 thorough QT 49 Medidur FA 49 microplasmin Phase III 49 modified REGENESIS 49 OLYMPIA registry 48 MEND CABG II 48 placebo controlled Phase III 48 Phase 1a 48 prospective multicenter randomized 48 initiate Phase IIb 48 Phase IIb clinical trials 48 satraplatin Phase 48 Myoblast 48 CVac 48 PHPT 48 Preliminary Scoping Study 48 STRIDE PD 48 Phase IIIb clinical 48 Zybrestat 48 Fully Covered Stent 48 EP #R 48 CA9 SCAN 48 Collategene 48 IIb clinical trial 48 RE LY ® 48 Systemic Sclerosis 48 RE SURGE 48 RHEO 48 renal artery stenting 48 Echocardiographic 48 CLIRS 48 Coronary CTA 48 FDG PET imaging 48 Phase IIb III 48 PMA submission 48 Phase 2a clinical trials 48 STARFlex 48 preclinical efficacy 48 multicentre study 48 Imaging Diagnostic 48 lorvotuzumab mertansine 48 SANVAR 48 pain palliation 48 ACOMPLIA R 47 buccal spray 47 ExTRACT TIMI 47 CARE HF 47 CardioFit 47 Endeavor DES 47 EFAPROXYN TM efaproxiral 47 biliary tract cancer 47 AOD# [002] 47 implantable centrifugal rotary 47 TASKi3 47 Thorough QT TQT 47 Alequel ™ 47 examining VBLOC Therapy 47 VBLOC 47 Zilver PTX stent 47 NCIC CTG 47 AMPAKINE CX# 47 epoetin alpha 47 NSABP B 47 BioZ ICG 47 Severn Tidal Power 47 UPLYSO 47 fosbretabulin 47 p# biomarker 47 Phase 1a clinical 47 randomized controlled Phase 47 cinacalcet 47 phase IIb III 47 Confirmatory 47 Glybera 47 phase IIa clinical 47 Phase #b/#a clinical 47 NEUVENGE 47 NuroPro PD 47 CHAMPION PCI 47 Initiates Clinical 47 Phase III multicenter 47 MicroThermX 47 Risk Stratification 47 Sirolimus eluting 47 Renal Cell Carcinoma RCC 47 ongoing Phase 1b 47 REPLACE Registry 47 Anavex #-# 47 Biphasic 47 Feasibility 47 CRMD# 47 ENDEAVOR III 46 femoral neck fracture 46 NeoDisc 46 PROactive Study 46 EVEREST II 46 Loïc Maurel MD 46 GORE VIABAHN Endoprosthesis 46 Trandolapril 46 Panzem ® 46 Embosphere 46 initiate multicenter 46 SIR Spheres 46 Exploratory IND 46 PRECISE 46 ImmuKnow R 46 ISAR TEST 46 Vascugel ® 46 prospective randomized multicenter 46 PRESEPT 46 Phase III ADT 46 chronic thromboembolic pulmonary 46 HepaSphere 46 Neovasc Reducer 46 NMP# BladderChek 46 Delcath Phase III 46 Phase III 46 phase Ib 46 Initiate Clinical Trial 46 ADVANCE PD 46 histamine dihydrochloride 46 genomic biomarker 46 Multicenter 46 Acute Ischemic Stroke 46 Antigen CEA 46 TUMT 46 Definitive Feasibility 46 symptomatic paroxysmal AF 46 Carotid endarterectomy 46 STOP AF trial 46 ADAGIO study 46 haematological cancers 46 Embolic Protection System 46 SNT-MC#/idebenone 46 Phase Ib clinical 46 TNM staging 46 multicenter randomized placebo controlled 46 BioControl 46 PreCISe 46 Huntexil 46 APEX AMI trial 46 Deferiprone 46 Dacogen decitabine 46 trastuzumab DM1 T DM1 46 APEX PD 46 CoreValve System 46 PARTNER Trial 46 vidofludimus 46 LungAlert TM 46 Phase IIIB IV 46 EINSTEIN DVT 46 sacral nerve stimulation 46 Carotid 46 formal pharmacokinetic PK 46 initiate Phase 2b 46 Phase 2a Study 46 SPIRIT FIRST 46 XIENCE V Stent System 46 Augment Injectable 46 randomized Phase IIb 46 CoAxia 45 Attrius ® 45 Gregory D. Casciaro 45 Resection 45 prospective multicenter 45 transthyretin amyloidosis 45 VTE prevention 45 interstitial brachytherapy 45 MYTHOS trial 45 Acute Decompensated Heart Failure 45 MiCK assay 45 levodopa induced dyskinesia 45 Angiotensin Therapeutic Vaccine 45 PD LID 45 GLP toxicology studies 45 Left Ventricular Dysfunction 45 lymphoid malignancies 45 brivaracetam 45 DiCOM 45 AGHD 45 phase IIb clinical 45 TNM classification 45 myeloid metaplasia 45 BRIM3 45 Onrigin 45 Phase IIb 45 ILLUSTRATE 45 refractory APL 45 metastatic malignant 45 ISTH 45 Alvesco R 45 Intergroup Exemestane Study 45 PROPATEN Bioactive Surface 45 MindUp BioResearch 45 TBC# 45 multicentre randomized 45 Embosphere Microspheres 45 Resolute stent 45 Phase II 45 EuroSCORE 45 K DOQI guidelines 45 ThermoDox R 45 Phase #/#a clinical 45 IIa clinical 45 CompuFlo 45 Proellex TM 45 VESTASYNC 45 Circulatory Support 45 Mycophenolate Mofetil 45 hoFH 45 optimal dosing regimens 45 efficacy evaluable 45 genitourinary cancers 45 prospective nonrandomized 45 SUTENT ® 45 Herlev Hospital 45 Sideguard ® 45 Agata Nickel Project 45 Phase III ThermoDox 45 TH# [003] 45 Prolor 45 patientswith 45 NADiA TM 45 Acute Myocardial Infarction 45 Viatronix V3D Colon 45 OmniWave 45 skeletally mature patients 45 thetreatment 45 IASLC 45 randomized controlled multicenter 45 FDG PET CT 45 PIX# [002] 45 phase IIb 45 randomized Phase 2b 45 Lucentis ranibizumab Genentech 45 STARFlex R 45 Breast Cancer Assay 45 laparoscopic radical nephrectomy 44 Bankable Feasibility 44 Cypher Sirolimus 44 confirmatory clinical 44 AtherOx 44 Shc 44 DEEP AF 44 Transthyretin 44 TAXUS V 44 Stereotactic Radiosurgery 44 novel oral anticoagulant 44 efficacy endpoint 44 atherosclerotic renal artery stenosis 44 mg/m2 cohort 44 GRAVITAS trial 44 pT2 44 PressureWire 44 bioFILM PA TM 44 radiation dosimetry 44 HuMax EGFr 44 multicenter randomized clinical 44 Sonolith i move 44 Common Toxicity Criteria 44 intravesical therapy 44 Phase III psoriasis 44 Intravenous Infusion 44 Glybera R 44 risk reducing salpingo 44 Company proprietary INACTINE 44 COR Analyzer 44 concurrent chemoradiation 44 cortical stimulation therapy 44 TQT 44 radiotherapeutic 44 ASSERT trial 44 EMEW 44 Chronic Heart Failure 44 percutaneous catheter 44 dual endothelin receptor antagonist 44 ORYX 44 Artificial Disc 44 AZILECT ® 44 ongoing Phase IIIb 44 RhuDex 44 interferon lozenges 44 CUSTOM III 44 heap leach amenability 44 Phase Ib IIa clinical 44 drug eluting stent DES 44 TransMID 44 Ancrod 44 hydroxamic acid 44 NP2 Enkephalin 44 Allograft 44 engineered urethras 44 Xelox 44 stereotactic radiotherapy 44 myocardial revascularization 44 RE LY 44 multicenter prospective 44 Pafuramidine 44 PRESEPT study 44 RE LY trial 44 V3D Colon 44 total thyroidectomy 44 carotid artery stenting CAS 44 NAVISTAR R 44 XYOTAX TM 44 VIBEX MTX 44 LungSign TM 44 Vascular Wrap 44 PROactive study 44 IMPACT DCM 44 VIAject 44 ABSORB trial 44 riociguat 44 DIABECELL ® 44 #km 2D seismic 44 Adaptive Radiation Therapy 44 placebo controlled clinical 44 USpella 44 Activity Assay 44 PrandiMet 44 RE COVER 44 CTEPH 44 adenomatous 44 Cardio3KG 44 AngioJet thrombectomy 44 sunitinib Sutent 44 Oxford Immunotec 44 reslizumab 44 fidaxomicin Phase 44 oral salmon calcitonin 44 oxybutynin topical gel 44 Premarket Approval 44 EGS# 44 clevidipine 44 doxorubicin Transdrug ® 44 Microarray analysis 43 Fractional Flow Reserve 43 OvaRex MAb 43 bronchopulmonary 43 endoluminal 43 Randomised 43 Solorel 43 T1a 43 Val HeFT 43 molecular diagnostic assay 43 ASTEROID 43 MERLIN TIMI 43 Arzerra ofatumumab 43 eluting stent 43 saphenous vein graft 43 PCQ 43 Smartlipo MPX 43 ECASS 43 randomized blinded 43 functional mitral regurgitation 43 ® pioglitazone HCl 43 BR.# 43 PROTECT II 43 Thrombolysis 43 Urocidin 43 omacetaxine mepesuccinate 43 Evoltra 43 NexStent Carotid Stent 43 multicenter clinical trials 43 Antisoma AS# 43 Delayed Graft Function 43 VITAL Trial 43 diagnosing coronary artery 43 Trobalt 43 SYNTAX trial 43 percutaneous interventions 43 VerifyNow P#Y# 43 Diazyme 43 Cardiac Ablation System 43 PhG alpha 1 43 neratinib 43 PI3 kinase inhibitors 43 Mammastatin Serum Assay 43 Computed Tomographic 43 Phase Ib 43 Histopathological 43 Metabolic Pharmaceuticals 43 multimodality therapy 43 Toraymyxin 43 Trovax 43 Teysuno 43 randomized multicentre 43 Stage IIB 43 Electronic Brachytherapy 43 metastatic gastric 43 phase IIb study 43 atmospheric leach 43 Troxatyl TM 43 neoadjuvant treatment 43 MADIT II 43 product Glybera R 43 ORENCIA ® 43 Medicsight PLC 43 Toric ICL 43 histologically confirmed 43 prospective randomized controlled 43 BioSTAR ® 43 Feasibility Studies 43 inhaled iloprost 43 ACTOS ® 43 plaque excision 43 PROLARIS 43 cervical lymph node 43 Carotid IMT 43 Cellulaze 43 Squalamine 43 Adenomas 43 Eamonn Quigley 43 Lymphoid 43 Diabetic Macular Edema DME 43 Merged Group 43 EBCC 43 Carotid Revascularization Endarterectomy vs. 43 scintigraphic 43 carotid artery stent 43 ToGA 43 LOCF analysis 43 stent binary restenosis 43 Safinamide 43 urothelial 43 Allogeneic 43 SEPET TM 43 icatibant 43 Orazol 43 seliciclib CYC# 43 Vitaxin 43 generation purine nucleoside 43 NEUPREX R 43 Aggressive Reduction 43 Endometrial 43 ASSERT 43 Phase III randomized controlled 43 Refractory Angina 43 laparoscopic partial nephrectomy 43 malignant ascites 43 mg kg BID 43 mechanical thrombectomy 43 MOLOGEN 43 OvaRex 43 randomized Phase III 42 completing Bankable Feasibility 42 Endeavor Drug Eluting 42 DNA methylation markers 42 HepDirect prodrug 42 OVATURE 42 ReValving 42 renal cysts 42 digital subtraction angiography 42 Hematopoietic 42 orally inhaled migraine 42 NOD SCID mice 42 myocardial necrosis 42 sDNA 42 intradiscal 42 subconjunctival injection 42 transesophageal 42 Therinject 42 BRIM2 42 transcranial Doppler ultrasound 42 pivotal bioequivalence 42 LUX Lung 42 Alternans 42 Goldknopf 42 Trofex 42 GW# [003] 42 PathFinderTG 42 Coherex FlatStent 42 AlloMap ® 42 tolerability pharmacokinetics 42 bone scintigraphy 42 double blinded randomized 42 FDG-PET/CT 42 STARFlex ® 42 HER2 antibody 42 photoprotective drug 42 Onconase 42 cardioverter defibrillator 42 OvaDx 42 NeuVax 42 HORIZONS AMI trial 42 Fäboliden 42 cardiac perfusion 42 fidaxomicin Phase 3 42 percutaneous vertebroplasty 42 Edwards SAPIEN valve 42 PresbyLens ® 42 NovoTTF #A 42 dual antiplatelet 42 NeuroFlo 42 Removab 42 coronary drug eluting 42 BGM Galectin 3 42 Oncoscience 42 MGd 42 Viprinex TM 42 Ketotransdel 42 IVTA 42 Phase1 42 Crystallographic 42 Phase 1b 42 Initiate Phase II 42 recurrent GBM 42 prospective randomized placebo 42 CardioPass 42 IIIA NSCLC 42 VerifyNow 42 OHR/AVR# 42 sulodexide 42 Microvolt T Wave Alternans 42 renal biopsy 42 photocoagulation 42 F FDG PET 42 Cardiotoxicity 42 WavSTAT 42 intralesional 42 ReN# 42 isoform selective 42 Beyondie Project 42 antithrombotic agents 42 bioresorbable stent 42 SRK Consulting SRK 42 Accelerated Partial Breast Irradiation 42 ACUITY trial 42 Cardiac Resynchronization Therapy 42 Sequenom CMM 42 AMPK activators 42 OnDose 42 QTinno ™ 42 pharmacokinetic pharmacodynamic 42 bronchoscopic 42 Pirfenidone 42 antiarrhythmic drug 42 Catena ® 42 transurethral 42 1Mtpa 42 Histological 42 ClearPath HDR 42 esophageal carcinoma 42 TLK# 42 MGuard ™ 42 feasibilty 42 multicenter clinical 42 Chemoradiation 42 PATH MVI 42 ritonavir boosted danoprevir 41 microvolt T wave alternans 41 bifurcation stent 41 HemeScan 41 DSMB recommended 41 mITT population 41 gastric carcinoma 41 SXEW 41 Mtsare Khevi Field 41 Emboshield 41 Lysis 41 DCVax R 41 Daxor 41 everolimus eluting stents 41 XIENCE 41 Hsp# Inhibitor 41 Selective Cardiac Myosin Activator 41 pelvic lymph node dissection 41 Sibutramine Cardiovascular Outcomes 41 WallFlex Biliary RX 41 TAXUS Liberté 41 Photodynamic 41 Endoscopic ultrasound 41 ILLUMINATE 41 Achieves Primary Endpoint 41 LRTI 41 Viralytics 41 QTinno TM 41 MAGE A3 ASCI 41 Inata Gold 41 Pinglu Project 41 Emphasys 41 DermTech International 41 ACE Inhibitor 41 receptor antagonism 41 Ligation 41 Tocosol Paclitaxel 41 pacemaker implantation 41 ASCT 41 TKAs 41 somatostatin analogues 41 reinitiation 41 TDLP 41 liver resection 41 coronary intervention 41 restenotic lesions 41 ASR XL 41 Computerized Tomography 41 efficacy tolerability 41 Acoustic Emission 41 prostate carcinoma 41 Histologic 41 PEG IFN 41 Cypher Stent 41 IMA# 41 HGD 41 SNT MC# 41 Arzerra TM 41 DCVax Brain 41 chemoradiation therapy 41 multicenter multinational 41 BREVAGen ™ 41 Assessment Scoping Study 41 initiate Phase 1b 41 intrahepatic cholangiocarcinoma 41 confirmatory Phase III 41 Certolizumab pegol 41 MelaFind R 41 Langer Heinrich Mine 41 Waelz kiln 41 INTERCEPT platelets 41 zotarolimus 41 urothelial carcinoma 41 lens IOL 41 GAMMAGARD 41 Intravascular 41 MGuard TM 41 Diabetic Retinopathy DR 41 Power Infuser 41 transrectal ultrasound 41 allogeneic hematopoietic stem cell 41 carcinoid tumors 41 colonoscopic 41 bioleach 41 antihypertensive therapies 41 Poster Discussion 41 GORE TAG ® 41 Serrote Deposit 41 Sipuleucel T 41 CALGB # [002] 41 VNP#M 41 PD2i Analyzer 41 microsatellite instability 41 symptomatic intracranial 41 aurora kinase 41 Elisabeth Lindner CEO 41 Boehringer Ingleheim 41 Pemetrexed 41 Axillary 41 Imatinib Mesylate 41 Angiox ® 41 Eli Lilly Alimta 41 chemotherapeutic regimen 41 trans urethral resection 41 oncological outcomes 41 ELIQUIS 41 Y Gastric Bypass Surgery 41 Mutation Analysis 41 punctal plug delivery 41 LPL deficiency 41 Phase IIb clinical 41 HCl capsules 41 CAMPATH 41 fibrillation AF 41 visceral metastases 41 Ostomy Wound Management 41 Prostate Px + 41 cardiac revascularization 41 multicenter Phase III 41 cediranib 41 Ercosplan 41 multiple myeloma MM 41 surgically resected 41 carotid endarterectomy CEA 41 Vertos II 41 Canariaco Norte copper 41 Pre Feasibility 41 RESOLUTE clinical 41 serum biomarker 41 Interbody Fusion 41 Aflibercept 41 induced macular edema 41 ALA PDT 41 cardiac repolarization 41 SCD HeFT 41 Heartmate II 41 Rubicon Filter 40 SENET 40 CT perfusion imaging 40 NSCL cancer 40 ZYBRESTAT fosbretabulin 40 medullary thyroid carcinoma 40 Medicsight ColonCAD 40 SYN# 40 Potelligent Technology 40 NEVO TM 40 PROSTVAC TM 40 MVA MUC1 IL2 40 NTx ® -# 40 autologous platelet gel 40 Phase IIa clinical 40 Monitoring ABPM 40 Desorption 40 DVT prophylaxis 40 AmpliChip 40 electrocardiography ECG 40 Bankable Feasibility Study BFS 40 Pyridorin 40 Zarnestra 40 bardoxolone methyl 40 ADMIRE HF 40 Silodosin 40 EnRhythm MRI SureScan pacing 40 relapsed MM 40 CATIE AD 40 Mina Justa Project 40 nonsmall cell lung cancer 40 neoadjuvant setting 40 trinucleotide repeat 40 MarginProbe 40 Nasdaq NYMX 40 Histopathologic 40 recurrent glioblastoma multiforme 40 non resectable 40 REBETOL combination 40 FirstCyte 40 nonrandomized 40 TREDAPTIVE 40 adecatumumab 40 deforolimus 40 feasibility 40 Matrix Phase 2b 40 angiographically 40 clinically meaningful efficacy 40 multimodality imaging 40 Abstract P# [002] 40 INTRABEAM 40 laser Doppler 40 adjuvant trastuzumab 40 drug tesmilifene 40 everolimus eluting 40 Buerger Disease 40 renal tumors 40 BSD-#/#D/MR 40 Photocure 40 Grower Harvester 40 Deforolimus 40 extracranial 40 gadolinium enhanced 40 MAIN FACTS 40 Myelodysplastic Syndrome 40 investigational antiplatelet 40 CombAT 40 Haplotype 40 peripheral arterial 40 Pelvic Organ Prolapse 40 rhMBL 40 recurrent metastatic 40 Aliskiren 40 radiation sensitizer 40 Myocardial Perfusion Imaging 40 Tripep 40 Phase 1b trial 40 HIFU tumor 40 Transcranial 40 CLIA waived status 40 intraepithelial neoplasia 40 RARP 40 generation rotary VAD 40 Piedras Verdes Mill 40 Intravitreal 40 endoscopic resection 40 aortic root replacement 40 QuadraSphere 40 airborne magnetic radiometric 40 VATS lobectomy 40 PI3K/Akt pathway inhibitor 40 TM Drug Eluting 40 briakinumab 40 endoscopic retrograde cholangiopancreatography ERCGrant Parpan 40 Dendreon Provenge 40 AMI acute myocardial 40 Microwave Ablation System 40 Phase III confirmatory 40 ELACYT 40 EOquin TM 40 CIMZIA TM certolizumab pegol 40 MRCOG 40 AspirinWorks ® 40 histologic diagnosis 40 azilsartan medoxomil 40 HDR brachytherapy 40 product ColonSentry TM 40 PARP Inhibitor 40 histologic examination 40 metallurgical flowsheet 40 glycoprotein IIb IIIa inhibitor 40 laparoscopic nephrectomy 40 Roche Herceptin 40 Oropharyngeal 39 mesangial 39 preoperative MRI 39 Chemical Vapor Deposition 39 Ozernoe 39 TRUS biopsy 39 ProDisc 39 cytological 39 HeartNet 39 Premarket Notification 39 nodal dissection 39 assessing T DM1 39 Caeté Project 39 Allient System 39 Corus CAD 39 tumor histology 39 randomized multicenter 39 preoperative diagnosis 39 carotid artery stenting 39 JETSTREAM G3 39 multivariate regression analysis 39 CT Perfusion 39 seminal vesicle invasion 39 bevirimat Study 39 BALF 39 GHIS 39 myoblast therapy 39 Sensitivity analyzes 39 PET CT scanning 39 Algae Biomass 39 Hedgehog antagonist 39 ZACTIMA 39 multivariable analyzes 39 unicompartmental knee arthroplasty 39 Minarco 39 GlucoLight 39 HIPEC 39 Rheos System 39 artery embolization 39 Phase 2b randomized 39 disease progression TTP 39 anti arrhythmic drug 39 Minproc 39 Gastrointestinal Cancer 39 alpha1 antitrypsin deficiency 39 TAXUS Liberte Stent 39 VTE prophylaxis 39 Pseudobulbar Affect 39 EG# [001] 39 Floating Liquefied Natural Gas 39 IPAH 39 FT# [001] 39 Arimidex anastrozole 39 modified REGENESIS Phase IIb 39 GH deficiency 39 transthoracic echocardiography 39 transabdominal 39 prasugrel Effient 39 StarClose 39 pediatric acute lymphoblastic 39 vesicoureteral reflux VUR 39 ABSORB 39 sacrocolpopexy 39 JORC compliant Mineral Resource 39 PET Scanner 39 Myoblast Program 39 AIM HIGH 39 Welichem 39 retinal vein occlusion induced 39 p# inhibitor 39 orBec 39 somatostatin analog 39 medically refractory 39 Delcath PHP System 39 BC SeraPro 39 Subgroup analysis 39 overburden characterization 39 ® natalizumab 39 Scoping Study Preliminary 39 Optical Coherence Tomography 39 Becton Dickinson BD 39 pretransplant 39 MOVIPREP ® 39 bazedoxifene selective estrogen receptor 39 Retreatment 39 Cytogenetic 39 Multimodality 39 Surgical resection 39 El Quevar project 39 multimodality 39 Elonva 39 ENSI 39 DCVax ® Brain 39 gastric adenocarcinoma 39 OMS# 39 Vascular Stent 39 SYGNIS 39 Histopathology 39 intravenous tPA 39 Prefeasibility 39 Custom NX 39 lymphoproliferative disorders 39 Nephros Therapeutics 39 wholly owned Twangiza 39 transthoracic 39 Retisert 39 Feasibility Study FS 39 GEMS TM 39 Orosi Mill Project 39 Humate P 39 anti arrhythmic 39 Melody Transcatheter Pulmonary Valve 39 Alair System 39 iDXA 39 pharmacodynamic markers 39 DCCR 39 process flowsheet 39 ductal lobular 39 TriActiv 39 MediTech 39 GV# [001] 39 gastrointestinal endoscopic 39 AEH 39 adjuvant cisplatin 39 Lovaxin C 39 ticagrelor Brilinta 39 benign prostatic hypertrophy BPH 39 Simuku 39 MVLWB 39 SonoLysis 39 peritoneal carcinomatosis 39 SBUMC 39 Lymph node 39 Myozyme alglucosidase alfa 39 Thymic 39 ACEI 39 nanopharmaceutical 39 Appropriateness Criteria 39 WHRT 39 Aggressive Drug Evaluation 39 Alton Boynton